Carol Pollock
Overview
Explore the profile of Carol Pollock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
4999
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beal B, Buizen L, Yeung E, Heath L, Houston L, Cherney D, et al.
Nephrol Dial Transplant
. 2025 Mar;
PMID: 40036884
Background: Insulin is a mainstay treatment for diabetes, but its use is associated with weight gain and hypoglycaemia. Data on the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on insulin...
2.
Pollock C, Carrero J, Kanda E, Ofori-Asenso R, Chen H, Garcia Sanchez J, et al.
Adv Ther
. 2025 Feb;
42(3):1419-1420.
PMID: 39899224
No abstract available.
3.
Chatur S, Vaduganathan M, Fletcher R, Perkovic V, Heerspink H, Arnott C, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39844714
Aims: The sodium-glucose cotransporter 2 inhibitor canagliflozin reduces the risk of heart failure (HF) hospitalization or cardiovascular death and chronic kidney disease (CKD) progression among patients with type 2 diabetes...
4.
Siriwardana A, Buizen L, Jun M, Kotwal S, Arnott C, Jardine M, et al.
Diabetes Obes Metab
. 2025 Jan;
27(4):1972-1979.
PMID: 39781601
Aim: SGLT2 inhibitors may be underused in older adults with type 2 diabetes due to concerns about safety and tolerability. This pooled analysis of the CANVAS Program and CREDENCE trial...
5.
6.
Pollock C, Carrero J, Kanda E, Ofori-Asenso R, Chen H, Garcia Sanchez J, et al.
Adv Ther
. 2024 Nov;
42(3):1393-1418.
PMID: 39611870
Introduction: Real-world data from patients with chronic kidney disease (CKD) are limited, particularly regarding clinical management, treatment patterns and health-related quality of life (HRQoL) in the context of new therapies...
7.
Staub E, Cao Q, Chen X, Pollock C
Pathology
. 2024 Nov;
57(1):81-86.
PMID: 39516170
Collecting urine samples in neonates by catheterisation or suprapubic puncture causes trauma, whereas self-adhesive collection bags can damage fragile skin. An alternative method is the collection of samples from urine-soaked...
8.
Milder T, Lin J, Pearson S, Costa J, Neuen B, Pollock C, et al.
Diabetes Obes Metab
. 2024 Nov;
27(2):997-1000.
PMID: 39511848
No abstract available.
9.
OHara D, Bassi A, Wilcox A, Jha V, Rathore V, DCruz S, et al.
BMJ Open
. 2024 Oct;
14(10):e081790.
PMID: 39438096
Objective: To determine whether a chemokine receptor type 2 antagonist, DMX-200 (repagermanium), in combination with an angiotensin receptor blocker, candesartan, improves clinical outcomes in people with COVID-19. Design: Prospective, multicentre,...
10.
Koshino A, Heerspink H, Jongs N, Badve S, Arnott C, Neal B, et al.
Nephrol Dial Transplant
. 2024 Sep;
PMID: 39304530
Background And Hypothesis: Studies in patients with heart failure have indicated that sodium-glucose cotransporter 2 (SGLT2) inhibitors increase iron use and enhance erythropoiesis. In this post-hoc analysis of the CREDENCE...